Mannkind (MNKD) Cash from Operations (2010 - 2026)
Mannkind (MNKD) reported Cash from Operations of 5365000.0 for Q1 2026, up 15.87% year-over-year from 4630207.74 in Q1 2025, and up 32.58% quarter-over-quarter from 7958000.0 in Q4 2025.
Mannkind (MNKD) Cash from Operations (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Cash from Operations data on file, last reported at 5365000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 5365000.0, up 15.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 19267000.0 (down 34.54% YoY), and the FY2025 annual result was 18255000.0, down 57.06% from the prior year.
- Cash from Operations rose to 5365000.0 in Q1 2026 per MNKD's latest filing, from 7958000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 23640000.0 in Q3 2025 and troughed at 31982000.0 in Q2 2022.
- A 5-year average of 518588.24 and a median of 2596000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations jumped 1012.37% in 2023, then tumbled 195.14% in 2025.
- A 5-year view of Cash from Operations shows it stood at 2376000.0 in 2022, then jumped by 1012.37% to 21678000.0 in 2023, then climbed by 4.46% to 22644000.0 in 2024, then tumbled by 135.14% to 7958000.0 in 2025, then surged by 32.58% to 5365000.0 in 2026.
- Business Quant data shows MNKD's Cash from Operations at 5365000.0 in Q1 2026, 7958000.0 in Q4 2025, and 23640000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn | -5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.37 Mn |
| Mar 31, 2026 | -5.37 Mn |
| Dec 31, 2025 | -7.96 Mn |
| Dec 31, 2025 | -7.96 Mn |
| Sep 30, 2025 | 23.64 Mn |
| Sep 30, 2025 | 23.64 Mn |
| Jun 30, 2025 | 8.95 Mn |
| Jun 30, 2025 | 8.95 Mn |
| Mar 31, 2025 | -6.38 Mn |
| Mar 31, 2025 | -6.38 Mn |
| Dec 31, 2024 | 22.64 Mn |
| Dec 31, 2024 | 22.64 Mn |
| Sep 30, 2024 | 9.33 Mn |
| Sep 30, 2024 | 9.33 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 6.70 Mn |
| Mar 31, 2024 | 6.70 Mn |
| Dec 31, 2023 | 21.68 Mn |
| Dec 31, 2023 | 21.68 Mn |